Excess Winter Mortality
This research provides a synthesis of environmental, biological, and clinical data to address the recurring phenomenon of “Excess Winter Mortality” (EWM), specifically focusing on the synchronized periodicity of respiratory viral infections and cardiovascular events. The central premise is that the seasonal “flu spike” is a localized manifestation of a broader biological vulnerability triggered by the Solar Nadir—the period surrounding the winter solstice where solar irradiance is at its minimum.
Data analysis of historical mortality trends (2015–2020) reveals that while influenza and pneumonia exhibit a sharp percentage spike in winter, cardiovascular disease represents a numerically dominant “winter hill.” For individuals over 65, the correlation between influenza activity and cardiovascular mortality reaches a Pearson coefficient of $r \ge 0.75$, indicating a deterministic relationship. Crucially, cardiac events often peak with a 14-to-21-day lag after the solstice, trailing the viral surge. This suggests that the heart is responding to a “Solar Debt” or is being stressed to failure by the systemic inflammation of concurrent viral infections.
The biological mechanism driving this vulnerability involves the loss of three critical solar bandwidths: UVB, UVA, and Near-Infrared (NIR) light. In northern latitudes (above 40° N), the winter sun is too low to produce UVB, leading to a “Vitamin D Winter” and a collapse of innate host defenses. Simultaneously, the reduction in UVA exposure depletes cutaneous stores of Nitric Oxide (NO). Nitric oxide is a potent vasodilator and antiviral; its depletion causes blood pressure to rise and arteries to stiffen, directly increasing the risk of thrombotic events exactly when viral pressures are highest.
Furthermore, the research identifies a “BMI Firewall”—a phenomenon where excess adipose tissue attenuates the penetration of healing NIR photons. NIR light normally stimulates subcellular melatonin within the mitochondria, acting as a primary antioxidant defense. For overweight populations, this protective signal is physically blocked, leaving the internal organs vulnerable to oxidative stress. This metabolic interference explains why certain demographics suffer disproportionately despite equal solar exposure.To bridge this seasonal gap, the research highlights the clinical efficacy of N-acetylcysteine (NAC). As a precursor to glutathione, NAC acts as a “chemical failsafe,” shifting the host from a state of immune non-responsiveness (anergy) to a balanced response (normoergy). Controlled trials indicate that a prophylactic protocol of 600 mg twice daily can reduce the conversion of infection to symptomatic illness by over 50%. By combining this chemical intervention with intentional “Solar Seeking” (midday UVA/NIR exposure), individuals can mitigate the compounded risks of the northern winter.
Details of the studies are on these pages
- Infographic: The reasons for Excess Winter Mortality
- Infographic: Heart disease is also affected
- Slideshow: Explains the solar deficit effects
- FAQ: The Science of the 2026 Solar-Viral Model
- Protocol:Immune Fortification
- Main Analysis: The Solstice Clock
Bibliography of Core Research Documents
The following documents constitute the primary evidence base for the Solar-Viral and Cardiovascular Periodicity model:
- Slusky, D. J., & Zeckhauser, R. J. (2020). Sunlight and protection against influenza. Economics & Human Biology, 38, 100863.
- Quantifies the 10% sunlight-to-1.1-point influenza index reduction.
- Walrand, S. (2021). Autumn COVID-19 surge dates in Europe correlated to latitudes, not to temperature-humidity, pointing to vitamin D as contributing factor. Scientific Reports, 11(1), 1981.
- Identifies the 34% UV threshold for pandemic surges.
- Cherrie, M., et al. (2021). Ultraviolet A radiation and COVID-19 deaths in the USA with replication studies in England and Italy. British Journal of Dermatology, 185(2), 363-370.
- Establishes the correlation between UVA/Nitric Oxide and a 32% reduction in mortality.
- De Flora, S., Grassi, C., & Carati, L. (1997). Attenuation of influenza-like symptomatology and improvement of cell-mediated immunity with long-term N-acetylcysteine treatment. European Respiratory Journal, 10(7), 1535-1541.
- The foundational “NACIS” study for the NAC 600mg BID protocol.
- Skutsch, M., Seheult, R., & Loya, J. (2022). A geographical approach to the development of hypotheses relating to COVID-19 death rates. Melatonin Research, 5(3), 278-294.
- Defines the “BMI Firewall” and the role of Near-Infrared (NIR) light in subcellular melatonin production.
- Nguyen, J. L., et al. (2016). Relationship between influenza activity and cardiovascular mortality. Epidemiology and Infection, 144(11), 2271-2280.
- Provides the Pearson Correlation ($r \ge 0.75$) between viral activity and heart failure.